• Making Sense of Sex in Clinical Trials

    Nov 12 | Clinical Research News | Roughly two-thirds of pivotal clinical trials leading to a drug approval by the U.S. Food and Drug Administration (FDA) now include women at rates either at or above the disease burden on the female population. Yet progress on their inclusion has “plateaued” since the FDA began releasing its Drug Trials Snapshots in 2015 because of “fundamental issues in not considering female biology." More

  • Less Can Be More When It Comes to Collecting Data in Studies

    Nov 11 | Clinical Research News | It is no secret that clinical trial protocols have grown increasingly complex, resulting in longer study durations, higher costs, and greater burden on patients and investigative sites. It has been a consistent, well-documented trend for more than two decades now. More

  • Next-Gen Weight-Loss Drug Moves Closer to Clinical Trials

    Nov 06 | Clinical Research News | Developing a “super-tolerable” weight loss drug is one of the biggest challenges in obesity medicine today. Researchers recently reported the creation of a promising molecule, tridecaneuropeptide (TDN), which reduces food intake without triggering the awful side effects often associated with glucagon-like peptide-1 (GLP-1) drugs such as Ozempic and Zepbound. More

  • Site Payments: Transparency, Timeliness, and Trust

    Nov 05 | Clinical Research News | For all the technological advances in clinical research, one issue remains stubbornly unresolved: timely, transparent payments to sites. At the latest SCOPE 365 ClinEco Connect, industry peers came together to examine why, after decades of discussion, site payment challenges persist, and what practical steps could finally close the gap. More

  • AI in Clinical Trials: Industry Leaders Discuss Implementation Challenges and Future Directions

    Nov 04 | Clinical Research News | At SCOPE Europe, Allison Proffitt hosted a panel of pharmaceutical industry leaders to discuss the real-world implementation of artificial intelligence in clinical trials, moving beyond theoretical benefits to address practical challenges and measurable outcomes. More

  • Pangaea, Microsoft Collaboration, First-in-Class Monoclonal Antibody for Cancer, New LLM Tech

    Oct 29 | Clinical Research News | Pangaea Data announces a collaboration with Microsoft; Ipsen acquires ImCheck Therapeutics; Flatiron Health released first-of-their-kind advances in LLM-extracted progression data and other uses; and more. More

  • Follow the Money: Best-in-Class Weight Loss Drug Trial, Novel eClinical Platform, Rheumatoid Arthritis, Other Diseases Treatments

    Oct 28 | Clinical Research News | Kailera Therapeutics advances injectable dual GLP-1/GIP receptor agonist; Almac Group plans Almac Trial Coordinator, a first-in-class interoperable clinical trial technology platform; Elvara advances their upcoming phase 2 clinical trial of its lead candidate ELV001; and more. More

  • GenAI Agents and Regulatory Compliance: Streamlining Unstructured Data Extraction Gets a Lift from GenAI Agentic Frameworks

    Oct 24 | Clinical Research News | Imagine that you’re a life sciences researcher tasked with answering a regulatory request that involves extracting meaningful data from over 200 clinical trial reports from various sources. You’re looking for patient demographics, study outcomes, adverse events, and dosage information. For decades, the industry has relied on manual effort, but GenAI agents enable far better unstructured data extraction. More

  • Europe's Clinical Trial Crisis: Industry Leaders Call for Urgent Action at SCOPE Europe

    Oct 22 | Clinical Research News | European clinical research is at a critical crossroads, industry leaders warned last week at SCOPE Europe. Regulatory fragmentation, site readiness challenges, and prolonged approval timelines are driving sponsors to more competitive markets in Asia and the United States. More

  • ‘Simple’ NLP Tool Streamlines Metastatic Cancer Research

    Oct 21 | Clinical Research News | Researchers at the Medical University of South Carolina (MUSC) are using a “super-simple” natural language processing (NLP) tool to streamline clinical research for metastatic brain cancer, a field where rapid advances in therapy are outpacing traditional methods of data analysis. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More